273 related articles for article (PubMed ID: 22382479)
1. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Hellwig TR; Peitz GJ; Gulseth MP
Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
[TBL] [Abstract][Full Text] [Related]
2. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Yarbrough PM; Varedi A; Walker A; Rondina MT
Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
[TBL] [Abstract][Full Text] [Related]
3. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
5. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Levine RL; Hursting MJ; McCollum D
Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
[TBL] [Abstract][Full Text] [Related]
6. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ; Soffer J
Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
[TBL] [Abstract][Full Text] [Related]
7. Argatroban therapy in women with heparin-induced thrombocytopenia.
Jang IK; Baron SJ; Hursting MJ; Anglade E
J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
[TBL] [Abstract][Full Text] [Related]
8. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Hursting MJ; Verme-Gibboney CN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
[TBL] [Abstract][Full Text] [Related]
10. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ
Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155
[TBL] [Abstract][Full Text] [Related]
11. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
Pendleton R; Wheeler MM; Rodgers GM
Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813
[TBL] [Abstract][Full Text] [Related]
12. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
[TBL] [Abstract][Full Text] [Related]
13. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Bain J; Meyer A
Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Murray PT; Hursting MJ
Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
[TBL] [Abstract][Full Text] [Related]
16. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Shapiro NL; Durr EA; Krueger CD
Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
[TBL] [Abstract][Full Text] [Related]
17. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Hursting MJ; Lewis BE; Macfarlane DE
Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
[TBL] [Abstract][Full Text] [Related]
18. Apparent argatroban resistance in a patient with elevated factor VIII levels.
Kennedy DM; Alaniz C
Ann Pharmacother; 2013; 47(7-8):e29. PubMed ID: 23737512
[TBL] [Abstract][Full Text] [Related]
19. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
Vo QA; Lin JK; Tong LM
Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]